Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 14, 2005; 11(42): 6707-6712
Published online Nov 14, 2005. doi: 10.3748/wjg.v11.i42.6707
Figure 1
Figure 1 Expression (A1-2) and activity (B) of H+-K+-ATPase in vivo. Lane M: PUC19 marker; lanes 1-6: piglets at 28, 35, 36.5, 38, 42, 45 d of age in control group, respectively; lanes 7-12: piglets at 28, 35, 36.5, 38, 42, 45 d of age in treatment, respectively. Bars without a common superscript representing significant differences between age groups (small letters a and b for control group and capital letters A and B for treatment group); aP<0.05 indicating differences between control and treatment groups at the same age.
Figure 2
Figure 2 Effect of CS on expression (A1-2) and activity (B) of H+-K+-ATPase in vitro. Lane M: PUC19 marker, lanes 1-2: control; lanes 3-4: low concentration group; lanes 5-6: moderate concentration group; lanes 7-8: high concentration group. aP<0.05 vs 0 mg/mL of CS.
Figure 3
Figure 3 Effect of CS on SS mRNA expression in vitro. Lane M: PUC19 marker, lanes 1 and 2: control; lanes 3 and 4: low concentration group; lanes 5 and 6: moderate concentration group; lanes 7 and 8: high concentration group (A,B). aP<0.05 vs 0 mg/mL of CS.